Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European best practice guidelines 17-18: adverse effects.

Literature DB >> 11052149

European best practice guidelines 17-18: adverse effects.

W H Hörl, C Jacobs, I C Macdougall, F Valderrábano, I Parrondo, B G Carveth, K Thompson.

Abstract

Mesh：

Substances：

Year: 2000 PMID： 11052149

Source DB: PubMed Journal: Nephrol Dial Transplant ISSN： 0931-0509 Impact factor: 5.992

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study .

Authors: Gérard London; Johannes Mann; David Goldsmith; Christian Combe; Frank Dellanna; Philippe Zaoui; Nadja Hoebel; Andriy Krendyukov; Karen MacDonald; Ivo Abraham
Journal: Clin Nephrol Date: 2018-01 Impact factor: 0.975

1 in total

European best practice guidelines 17-18: adverse effects.

1. Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study .

1. Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study .